Hepatitis B Immune Globulin Clinical Trials

• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
  ClinicalTrials.gov Identifier: NCT00000751 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00473824 - Recruiting
  Hepatitis C Virus; Liver Transplantation
  
• A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A
  ClinicalTrials.gov Identifier: NCT00139139 - Completed
  Hepatitis A
  
• Intravenous Pertussis Immune Globulin in Patients with Severe Childhood Pertussis Infection
  ClinicalTrials.gov Identifier: NCT00004422 - Active, not recruiting
  Pertussis; Whooping Cough
  
• Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin
  ClinicalTrials.gov Identifier: NCT00000580 - Completed
  Hepatitis B; Hepatitis, Viral, Human; Liver Diseases
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
  Multiple Sclerosis
  
• Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
  ClinicalTrials.gov Identifier: NCT00411697 - Active, not recruiting
  Hepatitis B
  
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Mth Schedule in Healthy Children
  ClinicalTrials.gov Identifier: NCT00289744 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
  ClinicalTrials.gov Identifier: NCT00289770 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adult Subjects
  ClinicalTrials.gov Identifier: NCT00289718 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
  ClinicalTrials.gov Identifier: NCT00291954 - Active, not recruiting
  Hepatitis B Infection
  
• Kidney Transplants in People with HIV Infection
  ClinicalTrials.gov Identifier: NCT00023478 - Active, not recruiting
  HIV Infections; End-Stage Renal Disease
  
• Studies of Immune Responses in Patients with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00155155 - Recruiting
  Hepatitis B
  
• Gradual Withdrawal of Immune System Suppressing Drugs in Hepatitis C Virus Patients Receiving a Liver Transplant
  ClinicalTrials.gov Identifier: NCT00135694 - Recruiting
  Hepatitis C; Hepatitis C, Chronic
  
• Long-Term Immune Persistence of GSK Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0,6 Mths Schedule in Healthy Adult Subjects
  ClinicalTrials.gov Identifier: NCT00289757 - Active, not recruiting
  Hepatitis A
  
• Long-Term Immune Persistence of GSK Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0,12 Mths Schedule in Healthy Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00291876 - Active, not recruiting
  Hepatitis A
  
• Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
  ClinicalTrials.gov Identifier: NCT00456625 - Recruiting
  Hepatitis B
  
• Immune Response to Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00006301 - Recruiting
  Hepatitis C
  
• Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
  ClinicalTrials.gov Identifier: NCT00175435 - Recruiting
  Hepatitis B
  
• Immune Response to Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00165919 - Recruiting
  Hepatitis C; HIV Infections
  
• Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
  ClinicalTrials.gov Identifier: NCT00168194 - Recruiting
  Hepatitis B; HIV Infections
  
• Study of the Immune Response to Hepatitis C Virus
  ClinicalTrials.gov Identifier: NCT00237432 - Recruiting
  Hepatitis C
  
• Safety of and Immune Response to a Hepatitis B Virus Vaccine Given with a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People
  ClinicalTrials.gov Identifier: NCT00100633 - Active, not recruiting
  HIV Infections; Hepatitis B
  
• Evaluate the Effect of Several Risk Factors That Are Likely to Influence the Immunogenicity of Combined Hepatitis A & B Vaccine vs Monovalent Hepatitis A & Hepatitis B Vaccines
  ClinicalTrials.gov Identifier: NCT00289731 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
  ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
  Hepatitis A
  
• Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
  ClinicalTrials.gov Identifier: NCT00499434 - Recruiting
  Acquired Immune Deficiency Syndrome; Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted; HIV Infections
  
• Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy
  ClinicalTrials.gov Identifier: NCT00542997 - Recruiting
  Common Variable Immunodeficiency; X-Linked Agammaglobulinemia
  
• Bone Marrow Transplantation Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002809 - Active, not recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; atypical chronic myeloid leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; ...
  
• Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
  ClinicalTrials.gov Identifier: NCT00547365 - Recruiting
  Multiple Myeloma and Plasma Cell Neoplasm
  
• Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients with Subacute Proximal Diabetic Neuropathy
  ClinicalTrials.gov Identifier: NCT00004407 - Active, not recruiting
  Diabetic Neuropathies
  
• Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00017550 - Active, not recruiting
  Refractory Anemia; refractory anemia with excess blasts; de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes
  
• Long Term Follow-up Studies 16-20 Yrs After Vaccine Dose of Hepatitis B Vaccine Administered With/Without Hepatitis B Immunoglobulins in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen
  ClinicalTrials.gov Identifier: NCT00240526 - Active, not recruiting
  Hepatitis B.
  
• Safety Study of an Intravenous Staphylococcus aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
  ClinicalTrials.gov Identifier: NCT00066989 - Completed
  Staphylococcal Infections
  
• Pilot Study Freeze and Transport Immune Cells
  ClinicalTrials.gov Identifier: NCT00138268 - Active, not recruiting
  Diphtheria; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  
• Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
  ClinicalTrials.gov Identifier: NCT00031291 - Completed
  Anthrax
  
• Safety Study of Anthrax Immune Globulin Derived From Human Serum
  ClinicalTrials.gov Identifier: NCT00448253 - Recruiting
  Symptoms of Inhalational Anthrax
  
• Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
  ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
  Hepatitis C; Hepatitis C, Chronic
  
• Hepatitis C Virus and the Humoral Immune System
  ClinicalTrials.gov Identifier: NCT00219999 - Recruiting
  Hepatitis C Virus
  
• Randomized Study of Intravenous Immunoglobulin in Patients with Mild or Moderate Myasthenia Gravis
  ClinicalTrials.gov Identifier: NCT00004682 - Active, not recruiting
  Myasthenia Gravis
  
• Evaluation of a New Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Lost Antibody After Previous Hepatitis B Vaccination.
  ClinicalTrials.gov Identifier: NCT00291980 - Active, not recruiting
  Hepatitis B
  
• Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Measles/Mumps/Rubella Vaccine & a Varicella (Chickenpox) Vaccine in Healthy Children
  ClinicalTrials.gov Identifier: NCT00197015 - Recruiting
  Hepatitis A
  
• Efficacy of High-Dose Intravenous Immune Globulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease
  ClinicalTrials.gov Identifier: NCT00288600 - Recruiting
  Hyperbilirubinemia; Erythroblastosis, Fetal
  
• Lg Term F-U Studies Yrs 16-20 After Vaccine Dose of Hepatitis B Vaccine in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg)& Hepatitis B Surface Antigen (HBsAg)
  ClinicalTrials.gov Identifier: NCT00240500 - Active, not recruiting
  Hepatitis B
  
• Antithymocyte Globulin and Cyclosporine Compared With Standard Therapy in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00004208 - Active, not recruiting
  Refractory Anemia; refractory anemia with ringed sideroblasts; refractory anemia with excess blasts; de novo myelodysplastic syndromes; ...
  
• A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00001999 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
  ClinicalTrials.gov Identifier: NCT00272493 - Active, not recruiting
  HIV Infections
  
• Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents
  ClinicalTrials.gov Identifier: NCT00141999 - Active, not recruiting
  Hepatitis
  
• Effectiveness of two Hepatitis B Vaccines in HIV-negative Youths
  ClinicalTrials.gov Identifier: NCT00107042 - Active, not recruiting
  Hepatitis B
  
• Study in Non-Responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
  ClinicalTrials.gov Identifier: NCT00230854 - Active, not recruiting
  Chronic Hepatitis C; Hepatitis, Viral, Human
  
• Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
  ClinicalTrials.gov Identifier: NCT00157079 - Completed
  Primary Immunodeficiency Disorders; Immune Thrombocytopenic Purpura (ITP); Kawasaki syndrome
  
• 48 Weeks Combination Therapy for Patients with HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
  ClinicalTrials.gov Identifier: NCT00114361 - Active, not recruiting
  Hepatitis B
  
• Safety and Behavior of S. aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients with S. aureus Bacteremia and Continuing Fever
  ClinicalTrials.gov Identifier: NCT00063089 - Completed
  Staphylococcal Infections
  
• Development of Immune Globulin Treatment for Avian Flu
  ClinicalTrials.gov Identifier: NCT00383071 - Recruiting
  Infectious Diseases; Influenza; Avian Flu
  
• A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
  ClinicalTrials.gov Identifier: NCT00044135 - Active, not recruiting
  Hepatitis B
  
• Long Term Follow-up Studies at Yrs 2,3,4 & 5, Where 2 Formulations of the Combined Hepatitis A & B Vaccine Was Compared
  ClinicalTrials.gov Identifier: NCT00197184 - Active, not recruiting
  Hepatitis A; Hepatitis B
  
• FibroScan in Patients with Hepatitis B and C Presenting for Liver Biopsy
  ClinicalTrials.gov Identifier: NCT00125762 - Recruiting
  Cirrhosis; Hepatitis B; Hepatitis C
  
• Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
  ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
  Hepatitis C; Hepatitis C, Chronic
  
• Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
  ClinicalTrials.gov Identifier: NCT00004286 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
  ClinicalTrials.gov Identifier: NCT00496002 - Recruiting
  Chronic Hepatitis; Hepatitis B
  
• Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
  ClinicalTrials.gov Identifier: NCT00195637 - Active, not recruiting
  Hereditary Inclusion Body Myopathy
  
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
  ClinicalTrials.gov Identifier: NCT00496158 - Recruiting
  Chronic Hepatitis; Hepatitis B
  
• Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00005937 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Differential Gene Expression of Liver Tissue and Blood from Individuals with Chronic Viral Hepatitis
  ClinicalTrials.gov Identifier: NCT00160940 - Recruiting
  Hepatitis C; Hepatitis B; Autoimmune Hepatitis; Liver Cirrhosis, Biliary; Cholangitis, Sclerosing
  
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy
  ClinicalTrials.gov Identifier: NCT00004772 - Completed
  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  
• A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
  ClinicalTrials.gov Identifier: NCT00088140 - Active, not recruiting
  Hepatitis C, Chronic
  
• Telbivudine versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
  ClinicalTrials.gov Identifier: NCT00076336 - Active, not recruiting
  Hepatitis; Hepatitis B, Chronic; Cirrhosis
  
• A Study to Compare Tenofovir versus Hepsera (adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00116805 - Active, not recruiting
  Chronic Hepatitis B
  
• A Clinical Research Study Designed To Determine If Treatment of Hepatitis C With Milk Thistle is More Effective Than No Treatment In Patients Infected With Both HIV And Hepatitis C
  ClinicalTrials.gov Identifier: NCT00246363 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
  ClinicalTrials.gov Identifier: NCT00069511 - Active, not recruiting
  Hepatitis C
  
• A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
  ClinicalTrials.gov Identifier: NCT00000720 - Completed
  HIV Infections
  
• Comparative Study of Pegasys plus Copegus in Treatment Naive Latino and Caucasian Patients with Chronic Hepatitis C, Genotype 1
  ClinicalTrials.gov Identifier: NCT00107653 - Active, not recruiting
  Hepatitis C
  
• Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients with Chronic Hepatitis B Infection
  ClinicalTrials.gov Identifier: NCT00120796 - Recruiting
  Hepatitis B
  
• Antibody Response and Immune Memory 15-18 Years After HBV Vaccination
  ClinicalTrials.gov Identifier: NCT00172328 - Recruiting
  Hepatitis B; Vaccine
  
• Lamivudine and Adefovir to Treat Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00023309 - Recruiting
  HBV; Hepatitis B; Hepatitis; Liver
  
• Peg-Ifn Dose Evaluations for Previously Untreated Subjects with Chronic Hepatitis C Infected with Genotype 1
  ClinicalTrials.gov Identifier: NCT00081770 - Active, not recruiting
  Chronic Hepatitis C
  
• Pegylated Interferon to Treat Chronic Hepatitis D
  ClinicalTrials.gov Identifier: NCT00023322 - Recruiting
  Hepatitis D
  
• Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral Medication
  ClinicalTrials.gov Identifier: NCT00188201 - Recruiting
  Hepatitis C; Hepatitis B
  
• Peginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients
  ClinicalTrials.gov Identifier: NCT00085917 - Active, not recruiting
  Hepatitis C; HIV Infections
  
• SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
  ClinicalTrials.gov Identifier: NCT00110799 - Active, not recruiting
  Hepatitis C; Thrombocytopenia
  
• Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral Therapy
  ClinicalTrials.gov Identifier: NCT00188240 - Recruiting
  Hepatitis C; Hepatitis B
  
• Long-Term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.
  ClinicalTrials.gov Identifier: NCT00519649 - Recruiting
  Hepatitis B
  
• IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00228852 - Recruiting
  T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency
  
• Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
  ClinicalTrials.gov Identifier: NCT00004850 - Recruiting
  Hepatitis C
  
• Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
  ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
  Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
  
• A Phase 1 Study of Tarvacin in Patients with Chronic Hepatitis C Virus Infection
  ClinicalTrials.gov Identifier: NCT00128271 - Active, not recruiting
  Hepatitis C
  
• Evaluation of the efficacy and safety of a high induction dose of Pegasys in combination with Copegus in patients with Chronic Hepatitis C who did not respond to previous treatment with PEG-Intron in combination with Rebetol/Ribavirin.
  ClinicalTrials.gov Identifier: NCT00087646 - Active, not recruiting
  Hepatitis
  
• Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004747 - Completed
  Cystic Fibrosis; Bacterial Infections
  
• Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients with Cirrhosis
  ClinicalTrials.gov Identifier: NCT00048724 - Active, not recruiting
  Chronic Hepatitis C; Cirrhosis
  
• Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected with HCV Genotype 2 or 3
  ClinicalTrials.gov Identifier: NCT00056862 - Recruiting
  Hepatitis C
  
• Study of Immune Ablation With High-Dose Cyclophosphamide and Anti-Thymocyte Globulin Followed By Autologous Peripheral Blood Stem Cell Rescue in Patients With Severe Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00014703 - No longer recruiting
  Crohn's Disease
  
• Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00128544 - Active, not recruiting
  Hepatitis B
  
• Study of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
  ClinicalTrials.gov Identifier: NCT00093093 - Active, not recruiting
  Chronic Hepatitis C
  
• VX-950-TiDP24-C210: A Study to Assess the Activity of Telaprevir on Hepatitis C Virus in Treatment naïve Patients Who Are Chronically Infected With Hepatitis C Genotype 4 Infection
  ClinicalTrials.gov Identifier: NCT00580801 - Recruiting
  Hepatitis C, Chronic
  
• Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects with Chronic Idiopathic Thrombocytopenic Purpura
  ClinicalTrials.gov Identifier: NCT00162006 - Completed
  Idiopathic Thrombocytopenic Purpura
  
• Natural History of Hepatitis C in Patients With Normal Liver Tests
  ClinicalTrials.gov Identifier: NCT00187473 - Active, not recruiting
  Chronic Hepatitis C
  
• Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B
  ClinicalTrials.gov Identifier: NCT00230503 - Active, not recruiting
  Hepatitis B, Chronic
  
• Modified Process Hepatitis B Vaccine in Healthy Neonates
  ClinicalTrials.gov Identifier: NCT00322361 - Active, not recruiting
  Hepatitis B; Hepatocellular Carcinoma
  
• Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
  ClinicalTrials.gov Identifier: NCT00336479 - Active, not recruiting
  Chronic Hepatitis C
  
• Phase 2 Study of VX-950, Pegasys® With and Without Copegus® in Hepatitis C
  ClinicalTrials.gov Identifier: NCT00372385 - Active, not recruiting
  Chronic Hepatitis C
  
• Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
  ClinicalTrials.gov Identifier: NCT00277862 - Active, not recruiting
  Hepatitis C